Skip to main content
Premium Trial:

Request an Annual Quote

Michael Klimas

Indi Molecular has appointed Michael Klimas its senior vice president of strategy and technical business development. He most recently was Merck Research Laboratories' executive director translational biomarker immuno-oncology and cardiometabolic lead. He started his career at AstraZeneca in neuroscience drug discovery, and he was a founding member of GE Medical Systems' molecular imaging strategy and business development effort. 

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.